Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 7/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4017596 | 0.86 | KDM4E (0.31) | APP | |
| SCHEMBL4363054 | 0.85 | APP (0.37) | APP | |
| SCHEMBL4013958 | 0.84 | — | — | |
| SCHEMBL4359990 | 0.79 | APP (0.31) | APP | |
| SCHEMBL4363055 | 0.73 | APP (0.37) | APP | |
| SCHEMBL3088925 | 0.72 | FFAR1 (0.37) | — | |
| SCHEMBL4017592 | 0.70 | KDM4E (0.34) | APP | |
| SCHEMBL4013952 | 0.70 | APP (0.31) | APP | |
| SCHEMBL4013956 | 0.70 | APP (0.31) | APP | |
| SCHEMBL13669347 | 0.67 | KMT2A (0.36) | APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1466176-A4 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | EPOCH BIOSCIENCES INC (US) | 2008-10-01 | — | — | EP | disclosed |
| US-6972339-B2 | Compounds and methods for fluorescent labeling | EPOCH BIOSCIENCES, INC. (US) | 2005-12-06 | — | — | US | disclosed |
| US-20050176066-A1 | Compounds and methods for fluorescent labeling | EPOCH BIOSCIENCES, INC. (US) | 2005-08-11 | — | — | US | disclosed |
| US-20050171340-A1 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | EPOCH BIOSCIENCES, INC. (US) | 2005-08-04 | — | — | US | disclosed |
| EP-1466176-A2 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | Epoch Biosciences, Inc. (US) | 2004-10-13 | — | — | EP | disclosed |
| WO-2003023357-A2 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | EPOCH BIOSCIENCES, INC. (US) | 2003-03-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176066-A1 | Compounds and methods for fluorescent labeling | HLCS, GLB1, TUBB | APP 3054/4885 |
| US-20050171340-A1 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | HLCS, GLB1, TUBB | APP 3054/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.